Protagonist Therapeutics to Participate in the JMP Securities Hematology and Oncology Summit

NEWARK, Calif., Dec. 1, 2022 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq: PTGX) ("Protagonist" or "the Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in a fireside chat presentation and host one-on-one meetings...

Click to view original post